Fred Alger Management »

Janux Therapeutics shares owned by Fred Alger Management

Quarter-by-quarter ownership of Janux Therapeutics (JANX) shares owned by Fred Alger Management from 13F filings

Historical chart of Fred Alger Management investment in Janux Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Janux Therapeutics held by Fred Alger Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Janux Therapeutics by Fred Alger Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $1.3M 24k 53.54

More positions owned by Fred Alger Management

NVIDIA Corporation Equity (NVDA)
Microsoft Corporation Equity (MSFT)
Meta Platforms Inc Class A Equity (META)
Amazon.com Equity (AMZN)
AppLovin Corp. Class A Equity (APP)
Nebius Group N.V. Class A Equity (NBIS)
Apple Equity (AAPL)
Broadcom Equity (AVGO)
Alphabet Inc. Class C Equity (GOOG)
Talen Energy Corp Equity (TLN)
Tesla Equity (TSLA)
Sea Limited Sponsored ADR Class A Equity (SE)
Netflix Equity (NFLX)
Western Digital Corporation Equity (WDC)
Natera Equity (NTRA)

View all positions for Fred Alger Management

Top funds holding Janux Therapeutics

RA Capital Management
FMR
Henderson Group
BlackRock
Paradigm Biocapital Advisors
Adage Capital Partners GP
Vanguard Group
State Street Corporation
OrbiMed Advisors
Point72 Asset Management
Logos Global Management
Geode Capital Management
Woodline Partners
T. Rowe Price Investment Management
Readystate Asset Management

View all funds holding Janux Therapeutics